厄洛替尼引起的手足综合征和脂溢性皮炎样皮疹。
Hand-foot syndrome and seborrheic dermatitis-like eruption induced by erlotinib.
作者信息
Benomar Sophia, Boutayeb Saber, Afifi Yassir, Hamada Syrine, Bouhllab Jamila, Hassam Badreddine, Errihanni Hassan
机构信息
Department of dermatology, Ibn Sina Hospital, Mohamed V University of Rabat, Morocco.
出版信息
Dermatol Online J. 2009 Nov 15;15(11):2.
PMID:19951638
Abstract
Erlotinib is an epidermal growth factor receptor tyrosine kinase inhibitor that is responsible for several cutaneous side effects. We report a case of hand-foot syndrome associated with a papulo-pustular and seborrheic dermatitis-like eruption of the face in a 61-year-old patient treated with erlotinib for lung cancer.
摘要
厄洛替尼是一种表皮生长因子受体酪氨酸激酶抑制剂，可导致多种皮肤副作用。我们报告了一例61岁肺癌患者，在用厄洛替尼治疗期间出现了手足综合征，并伴有面部丘疹脓疱样和脂溢性皮炎样皮疹。
Zotero 插件